A phase I study of Erbitux [cetuximab] and gemcitabine with radiation therapy for locally advanced pancreas cancer.
Phase of Trial: Phase I
Latest Information Update: 17 May 2012
At a glance
- Drugs Cetuximab (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
- 19 Jul 2010 Planned end date changed from 1 Oct 2010 to 1 Nov 2011 as reported by ClinicalTrials.gov.
- 04 Jan 2008 Status changed from suspended to in progress.